Stocks
Funds
Screener
Sectors
Watchlists

Latest Blue Owl Capital Holdings LP Stock Portfolio

Blue Owl Capital Holdings LP Performance:
2024 Q3: 2.01%YTD: 4.19%2023: 35.04%

Performance for 2024 Q3 is 2.01%, and YTD is 4.19%, and 2023 is 35.04%.

About Blue Owl Capital Holdings LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Blue Owl Capital Holdings LP reported an equity portfolio of $518.4 Millions as of 30 Sep, 2024.

The top stock holdings of Blue Owl Capital Holdings LP are , , . The fund has invested 13.6% of it's portfolio in NUVEEN CHURCHILL DIRECT LEND and 8.2% of portfolio in KLAVIYO INC.

The fund managers got completely rid off TOAST INC (TOST) and CELCUITY INC (CELC) stocks. They significantly reduced their stock positions in PLUM ACQUISITION CORP III (APTM), MINERALYS THERAPEUTICS INC and ULTRAGENYX PHARMACEUTICAL IN (RARE). Blue Owl Capital Holdings LP opened new stock positions in NUVEEN CHURCHILL DIRECT LEND, PROSHARES TR (EET) and CONDUENT INC (CNDT). The fund showed a lot of confidence in some stocks as they added substantially to ENGENE HOLDINGS INC, JANUX THERAPEUTICS INC (JANX) and PLUM ACQUISITION CORP III (APTM).

Blue Owl Capital Holdings LP Annual Return Estimates Vs S&P 500

Our best estimate is that Blue Owl Capital Holdings LP made a return of 2.01% in the last quarter. In trailing 12 months, it's portfolio return was 21.2%.

New Buys

Ticker$ Bought
nuveen churchill direct lend70,369,000
proshares tr23,559,200
conduent inc13,553,000
holley inc7,503,580
lanzatech global inc5,589,640
ccc intelligent solutions hl5,051,000
centessa pharmaceuticals plc4,077,450
aeon biopharma inc3,508,260

New stocks bought by Blue Owl Capital Holdings LP

Additions

Ticker% Inc.
engene holdings inc898
janux therapeutics inc100
plum acquisition corp iii75.00
syros pharmaceuticals inc51.34
engene holdings inc24.86
structure therapeutics inc18.18
larimar therapeutics inc7.96
pyxis oncology inc7.65

Additions to existing portfolio by Blue Owl Capital Holdings LP

Reductions

Ticker% Reduced
plum acquisition corp iii-78.57
mineralys therapeutics inc-56.45
ultragenyx pharmaceutical in-39.14
keros therapeutics inc-22.2
disc medicine inc-18.58
tourmaline bio inc-10.78
mereo biopharma group plc-5.57
acelyrin inc-4.51

Blue Owl Capital Holdings LP reduced stake in above stock

Sold off

Ticker$ Sold
toast inc-8,312,840
celcuity inc-1,064,700

Blue Owl Capital Holdings LP got rid off the above stocks

Sector Distribution

Blue Owl Capital Holdings LP has about 52.8% of it's holdings in Others sector.

Sector%
Others52.8
Healthcare35
Technology9.4
Consumer Cyclical1.5

Market Cap. Distribution

Blue Owl Capital Holdings LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED53.9
SMALL-CAP28.6
MID-CAP9
MICRO-CAP8.3

Stocks belong to which Index?

About 34.5% of the stocks held by Blue Owl Capital Holdings LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others65.5
RUSSELL 200034.5
Top 5 Winners (%)%
BKSY
blacksky technology inc
323.2 %
AQST
aquestive therapeutics inc
83.8 %
CMPX
compass therapeutics inc
83.5 %
BLND
blend labs inc
58.9 %
RARE
ultragenyx pharmaceutical in
32.8 %
Top 5 Winners ($)$
RARE
ultragenyx pharmaceutical in
3.6 M
AQST
aquestive therapeutics inc
2.8 M
CMPX
compass therapeutics inc
2.4 M
KROS
keros therapeutics inc
1.6 M
PLRX
pliant therapeutics inc
1.4 M
Top 5 Losers (%)%
SYRS
syros pharmaceuticals inc
-48.0 %
OMGA
omega therapeutics inc
-41.1 %
BAER
bridger aerospace grp hldgs
-30.8 %
PIII
p3 health partners inc
-23.6 %
KPLT
katapult holdings inc
-23.0 %
Top 5 Losers ($)$
LRMR
larimar therapeutics inc
-3.1 M
CGEM
cullinan therapeutics inc
-1.4 M
SYRS
syros pharmaceuticals inc
-1.0 M
EVCM
evercommerce inc
-1.0 M
OMGA
omega therapeutics inc
-0.9 M

Blue Owl Capital Holdings LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Blue Owl Capital Holdings LP

Blue Owl Capital Holdings LP has 136 stocks in it's portfolio. About 65.1% of the portfolio is in top 10 stocks. LRMR proved to be the most loss making stock for the portfolio. RARE was the most profitable stock for Blue Owl Capital Holdings LP last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions